Skip to main content Help with accessibility Skip to main navigation

January 2023 updates to the website

The website has now been updated following January's LSCMMG

The following guidelines have been added/updated:

LSCMMG ONS Guideline - Updated

Psoriasis Biologic Treatment Pathway - Updated 

Olopatadine hydrochloride 600 micrograms / mometasone furoate monohydrate 25 micrograms per actuation nasal spray (Ryaltris®) - Updated

Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (Sativex®) For Refractory Neuropathic Pain - Updated

The following Items will be updated and added to the website following the next Pharmacy and Medicines Policy Task and Finish Group Meeting:

Degarelix for treatment of adult male patients with advanced hormone-dependent prostate cancer without spinal metastases